Neoadjuvant Chemotherapy Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy
Conditions: HNSCC; Radiotherapy; PD-1 Interventions: Drug: PD-1inhibitor; Radiation: concurrent chemoradiotherapy Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; First People's Hospital of Foshan; First Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital& Institute of Guangzhou Medical University; Affiliated Cancer Hospital of Shantou University Medical College Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
Condition: Locally Advanced Rectal Cancer Interventions: Drug: AK104; Drug: Capecitabine; Radiation: Neoadjuvant Radiotherapy Sponsors: Sun Yat-sen University; Akeso; Haplox Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials